Buy OMNITROPE 15 MG 45 IU Cartridge Online

OMNITROPE 15 mg is a synthetic form of human growth hormone (hGH) that is used to treat growth hormone deficiency in both children and adults.

Composition:
The active ingredient in OMNITROPE 15 mg is Somatropin, a recombinant hGH that is identical to the natural form of the hormone produced by the human body.

Uses:
OMNITROPE 15 mg is primarily used to treat growth hormone deficiency in children, as well as certain medical conditions that can cause short stature or growth failure. It can also be used to treat adults with hGH deficiency, and to improve muscle mass and reduce body fat in people with HIV-associated wasting.

HOW TO USE:
OMNITROPE 15 mg is administered via subcutaneous injection, usually by the patient or a caregiver. The exact dosage and frequency of injections will depend on the individual patient’s needs and medical condition.

Dosage:
The recommended dose of OMNITROPE 15 mg may range from 0.15 mg/kg to 0.3 mg/kg per week, depending on the patient’s age and condition.

Storage Conditions:
OMNITROPE 15 mg should be stored in the refrigerator at 2-8°C (36-46°F) before reconstitution and after reconstitution it can be kept in the refrigerator up to 28 days.

Mechanism of action:
OMNITROPE 15 mg works by stimulating the production of insulin-like growth factor (IGF-1), which is responsible for the growth of bones, muscles, and other tissues in the body. By increasing hGH levels, OMNITROPE 15 mg can help stimulate growth and development in patients who have a deficiency of the hormone.

Precautions:
OMNITROPE 15 mg should not be given to patients with active malignancy, and it should be used with caution in patients with diabetes, intracranial lesions, or a history of pancreatitis. It is also important to monitor blood glucose levels in patients using OMNITROPE 15 mg.

Contraindications:
OMNITROPE 15 mg should not be used in patients with a hypersensitivity or allergic reaction to somatropin or any of its components.

Interactions:
OMNITROPE 15 mg may interact with glucocorticoids, cyclosporine, and some anticonvulsant medications, and it may also affect the metabolism of other drugs. It is important to discuss all medications and supplements with a healthcare provider before starting treatment with OMNITROPE 15 mg.

Overdose:
In the event of an overdose of OMNITROPE 15 mg, the patient should seek immediate medical attention. Symptoms of overdose may include headache, nausea, vomiting, and fatigue.

Side effects:
Common side effects of OMNITROPE 15 mg can include injection site reactions, headaches, joint pain, and swelling. Less common but more serious side effects may include increased intracranial pressure, pancreatitis, and allergic reactions. Patients should discuss any concerning or unusual symptoms with their healthcare provider.